BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ni N, Deng F, He F, Wang H, Shi D, Liao J, Zou Y, Wang H, Zhao P, Hu X, Chen C, Hu DA, Sabharwal M, Qin KH, Wagstaff W, Qin D, Hendren-santiago B, Haydon RC, Luu HH, Reid RR, Shen L, He T, Fan J. A one-step construction of adenovirus (OSCA) system using the Gibson DNA Assembly technology. Molecular Therapy - Oncolytics 2021;23:602-611. [DOI: 10.1016/j.omto.2021.11.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Sallard E, Zhang W, Aydin M, Schröer K, Ehrhardt A. The Adenovirus Vector Platform: Novel Insights into Rational Vector Design and Lessons Learned from the COVID-19 Vaccine. Viruses 2023;15. [PMID: 36680244 DOI: 10.3390/v15010204] [Reference Citation Analysis]
2 Zhong J, Tian L, Gou Y, Zhao P, Dong X, Guo M, Zhao G, Li A, Hao A, He T, Fan J. BMP4 reprograms glucose metabolism in hepatocellular carcinoma (HCC) cells by upregulating glycogen synthesis through the SMAD/SLC2A1 (GLUT1) signaling axis.. [DOI: 10.21203/rs.3.rs-2347974/v1] [Reference Citation Analysis]
3 Lu S, Barry MA. Locked and loaded: engineering and arming oncolytic adenoviruses to enhance anti-tumor immune responses. Expert Opinion on Biological Therapy 2022. [DOI: 10.1080/14712598.2022.2139601] [Reference Citation Analysis]
4 Zhang L, Luo W, Liu J, Xu M, Peng Q, Zou W, You J, Shu Y, Zhao P, Wagstaff W, Zhao G, Qin K, Haydon RC, Luu HH, Reid RR, Bi Y, Zhao T, He T, Fu Z. Modeling lung diseases using reversibly immortalized mouse pulmonary alveolar type 2 cells (imPAC2). Cell Biosci 2022;12:159. [DOI: 10.1186/s13578-022-00894-4] [Reference Citation Analysis]